DPP4 is also highly expressed in the liver and circulation in NAFLD and nonalcoholic steatohepatitis (NASH) patients [7, 8], and there is increasing evidence that DPP4 is highly involved in the development of chronic liver diseases [5, 9]. Here, DPP4 is linked to metabolic dysfunction-associated steatotic liver disease.